Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2001 1
2005 2
2006 2
2007 2
2008 2
2009 3
2010 1
2011 3
2012 3
2013 3
2014 1
2015 2
2016 1
2021 3
2022 3
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.
Darrigade AS, Théophile H, Sanchez-Pena P, Milpied B, Colbert M, Pedeboscq S, Pistone T, Jullié ML, Seneschal J. Darrigade AS, et al. Allergy. 2021 Oct;76(10):3194-3196. doi: 10.1111/all.14981. Epub 2021 Jul 3. Allergy. 2021. PMID: 34143448 Free PMC article. No abstract available.
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Meriglier E, Rivoisy C, Hessamfar M, Bernard N, Aureau I, Lapoirie J, Contis A, Sacher F, Sacristan B, Lahouati M, Pedeboscq S, Vandenhende MA, Bouchet S, Bonnet F. Meriglier E, et al. J Antimicrob Chemother. 2021 Jan 19;76(2):482-486. doi: 10.1093/jac/dkaa441. J Antimicrob Chemother. 2021. PMID: 33221868 Free PMC article.
HIPK1 drives p53 activation to limit colorectal cancer cell growth.
Rey C, Soubeyran I, Mahouche I, Pedeboscq S, Bessede A, Ichas F, De Giorgi F, Lartigue L. Rey C, et al. Cell Cycle. 2013 Jun 15;12(12):1879-91. doi: 10.4161/cc.24927. Epub 2013 May 15. Cell Cycle. 2013. PMID: 23676219 Free PMC article.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
31 results